Edesa Biotech EDSA
NASDAQ EDSA
$4.80 +0.08 (+1.69%)
As of: Sep 10, 2026 · 12:10 PM EDT

Edesa Biotech (EDSA) Work In Process (2015)

Edesa Biotech's (EDSA) quarterly Work In Process came in at $137021.0 in Q3 2015, up 69.75% quarter-over-quarter from $80720.0 in Q2 2015.

Analysis

Edesa Biotech (EDSA) Work In Process (2015) Analysis & Trends

Edesa Biotech has disclosed Work In Process across 1 years of filings, most recently posting $137021.0 for Q3 2015.

  • In Q3 2015, Work In Process changed N/A year-over-year to $137021.0; the TTM figure through Sep 2015 stood at $137021.0 (changed N/A YoY), while the FY2015 annual figure was $137021.0, changed N/A from the prior year.
  • Work In Process came in at $137021.0 for Q3 2015 at Edesa Biotech, up from $80720.0 in the prior quarter.
  • In the past five years, Work In Process ranged from a high of $137021.0 in Q3 2015 to a low of $80720.0 in Q2 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.59 Bn 192.60 Bn 7.24 Bn
2 Gilead Sciences 180.21 Bn 177.03 Bn 6.22 Bn
3 Vertex Pharmaceuticals 131.41 Bn 123.56 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.94 Bn 73.94 Bn 3.93 Bn
5 Argenx Se 60.60 Bn 55.41 Bn 1.37 Bn
6 Moderna 53.61 Bn 48.47 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.49 Bn 30.18 Bn 992.69 Mn
8 Biogen 31.83 Bn 30.54 Bn 1.96 Bn
9 Roivant Sciences 29.14 Bn 29.14 Bn 1.16 Mn
10 Edesa Biotech 43.24 Mn 43.24 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2015 137,021.00
Jun 30, 2015 80,720.00